The Trip Report reports on three innovative companies in February 2022, TrippVR, Eleusis, and Mindstate Design Labs.
Companies Featured
EleusisEleusis is a clinical-stage life sciences company that studies and develops psychedelic drugs for therapeutic use. Since 2013 the company has been researching psychedelics and is now developing ELE-Psilo (psilocybin) for depression that is in Phase I.
Mindstate Design
A preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.